Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
Critical Reviews™ in Eukaryotic Gene Expression
Импакт фактор: 1.841 5-летний Импакт фактор: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN Печать: 1045-4403
ISSN Онлайн: 2162-6502

Выпуски:
Том 29, 2019 Том 28, 2018 Том 27, 2017 Том 26, 2016 Том 25, 2015 Том 24, 2014 Том 23, 2013 Том 22, 2012 Том 21, 2011 Том 20, 2010 Том 19, 2009 Том 18, 2008 Том 17, 2007 Том 16, 2006 Том 15, 2005 Том 14, 2004 Том 13, 2003 Том 12, 2002 Том 11, 2001 Том 10, 2000 Том 9, 1999 Том 8, 1998 Том 7, 1997 Том 6, 1996 Том 5, 1995 Том 4, 1994

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.v26.i1.60
pages 49-62

Dual Role of p21 in the Progression of Cancer and Its Treatment

Amna Parveen
Pharmaceutical Resources Botany Laboratory, Department of Pharmacognosy, College of Pharmacy, Chung-ang University, Seoul, Republic of Korea; Department of Pharmaceutical Chemistry, Government College University Faisalabad, Pakistan
Muhammad Sajid Hamid Akash
Department of Pharmaceutical Chemistry, Government College University Faisalabad, Pakistan
Kanwal Rehman
Institute of Pharmacy, Physiology and Pharmacology, University of Agriculture, Faisalabad, Pakistan
Whang Wan Kyunn
Pharmaceutical Resources Botany Laboratory, Department of Pharmacognosy, College of Pharmacy, Chung-ang University, Seoul, Republic of Korea

Краткое описание

Cancer develops due to an imbalance between cell proliferation and cell death. Various mechanisms of carcinogenesis as well as of novel anticancer agents that could be targeted for the treatment of cancer have been proposed by different studies. Among these, p21 is recognized as a potent cyclin-dependent kinase inhibitor that facilitates cell-cycle arrest by interacting with different stimuli such as p53, DNA repair process, CDK, E2F1, MYC, PCNA, STAT3 AP4, proteasomes, K1F, CDX2, and ER-α. p21 acts both as a tumor-suppressor gene and an inhibitor of apoptosis by interacting with various molecules and transition factors. In this review, we discuss the complex role of p21 in the development of cancer and as a target in its treatment. We conclude that, in the future, the tumor-suppressor activity of p21 should be the focus of a novel treatment strategies, which may lead to the devolvement of new and selective anti-cancer agents for the targeted therapy of cancers.

Ключевые слова: p21, p53, cancer treatment, cyclin-dependent kinases.

Articles with similar content:

Dual Roles of Kruppel-Like Factor 4 as a Tumor Suppressor or Oncogene
Forum on Immunopathological Diseases and Therapeutics, Vol.7, 2016, issue 1-2
Peng-Sheng Zheng, Wen-Ting Yang
Nucleic Acid Modulation of Gene Expression: Approaches for Nucleic Acid Therapeutics Against Cancer
Critical Reviews™ in Eukaryotic Gene Expression, Vol.15, 2005, issue 2
Yuji Nakata, Susan Shetzline, Alan M. Gewirtz, Tae-Kon Kim
Inhibition of Epithelial-to-Mesenchymal Transition (EMT) in Cancer by Nitric Oxide: Pivotal Roles of Nitrosylation of NF-κB, YY1 and Snail
Forum on Immunopathological Diseases and Therapeutics, Vol.3, 2012, issue 2
Stavroula Baritaki, Benjamin Bonavida
The Possible Interactions and Therapeutic Roles of Lithium Chloride and Midkine on Cancer Treatment
Critical Reviews™ in Oncogenesis, Vol.24, 2019, issue 1
Ayhan Bilir, Mehmet Yakup Tuna, Ahmet Sükrü Aynacioglu
The Oncogenic Role of Yin Yang 1
Critical Reviews™ in Oncogenesis, Vol.16, 2011, issue 3-4
Daniel B. Stovall, Guangchao Sui, Kazushi Inoue, Qiang Zhang